ALT 0.00% 0.1¢ analytica limited

Well done for DYOR and in the end that's probably the number one...

  1. 6,725 Posts.
    lightbulb Created with Sketch. 14
    Well done for DYOR and in the end that's probably the number one thing to do at this end of the market.

    And I am pretty sure most suffers will not use such a device.
    I thought however the target market was those women whose problem was such that they sort out a clinician. ?
    Where not the original figures touted based on 1% of the 15% who said they would use such a device?

    I cant look it up atm so don't take my word for it.

    Cheers

    Oscar
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.